Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Dermatology
Published in: BMC Dermatology 1/2012

Open Access 01-12-2012 | Study protocol

Chronic hand eczema - self-management and prognosis: a study protocol for a randomised clinical trial

Authors: Annette Mollerup, Niels Kren Veien, Jeanne Duus Johansen

Published in: BMC Dermatology | Issue 1/2012

Login to get access

Abstract

Background

Hand eczema has a one-year prevalence of approximately 10 % in the general Danish population. Often the disease becomes chronic with numerous implications for the individual’s daily life, occupation and quality of life. However, no guidelines of self-management recommendations beyond the acute stage are given. Self-management of the disease is pivotal and involves self-monitoring of the condition, medication adherence, and preventive behaviour. Interventions best to support the individual in this ongoing process need to be developed.

Methods/design

This paper describes the design of a randomised clinical trial to test a newly developed intervention of individual counselling versus conventional information. 300 patients consecutively referred to dermatologic treatment at two different settings are individually randomised to either the intervention programme, named ‘The Healthy Skin Clinic’ or to the control group. Block-wise randomisation according to setting and gender is carried out.
The intervention offers a tool for self-monitoring; basic and specific individual counselling; the possibility of asynchronous communication with the intervention team; and an electronic patient dialogue forum. Primary outcome variable is objective assessment of the hand eczema severity performed at baseline prior to randomisation, and repeated at six months follow-up. Secondary outcome variables are dermatology related life quality and perceived global burden of disease.

Discussion

The trial aims at evaluating a newly developed guidance programme which is expected to support self-management of patients referred to dermatology treatment due to chronic hand eczema. The design of the protocol is pragmatic with blinding of neither participants nor the investigator. Thus, in the interpretation of the results, the investigator takes into account effects that may be attributed to actors of the interventions rather than the intervention per se as well of potential observer bias. Inclusion criterions are wide in order to increase transferability of the results.

Trial registration

The trial is registered in ClinicalTrials.Gov with registration number NCT01482663.
Appendix
Available only for authorised users
Literature
1.
Thyssen JP, Johansen JD, Linneberg A, Menne T: The epidemiology of hand eczema in the general population–prevalence and main findings. Contact Dermatitis 2010, 62: 75–87. 10.1111/j.1600-0536.2009.01669.xCrossRefPubMed
2.
Hald M, Berg ND, Elberling J, Johansen JD: Medical consultations in relation to severity of hand eczema in the general population. Br J Dermatol 2008, 158: 773–777. 10.1111/j.1365-2133.2007.08431.xCrossRefPubMed
3.
Veien NK, Hattel T, Laurberg G: Hand eczema: causes, course, and prognosis I. Contact Dermatitis 2008, 58: 330–334. 10.1111/j.1600-0536.2008.01345.xCrossRefPubMed
4.
Menne T, Johansen JD, Sommerlund M, Veien NK: Hand eczema guidelines based on the Danish guidelines for the diagnosis and treatment of hand eczema. Contact Dermatitis 2011, 65: 3–12. 10.1111/j.1600-0536.2011.01915.xCrossRefPubMed
5.
Meding B, Wrangsjo K, Jarvholm B: Fifteen-year follow-up of hand eczema: persistence and consequences. Br J Dermatol 2005, 152: 975–980. 10.1111/j.1365-2133.2005.06494.xCrossRefPubMed
6.
Cvetkovski RS, Zachariae R, Jensen H, Olsen J, Johansen JD, Agner T: Quality of life and depression in a population of occupational hand eczema patients. Contact Dermatitis 2006, 54: 106–111. 10.1111/j.0105-1873.2006.00783.xCrossRefPubMed
7.
Diepgen TL, Elsner P, Schliemann S, Fartasch M, Kollner A, Skudlik C, John SM, Worm M: Guideline on the management of hand eczema ICD-10 Code: L20. L23. L24. L25. L30. J Dtsch Dermatol Ges 2009,7(Suppl 3):S1–16.PubMed
8.
Holness DL, Nethercott JR: Is a worker's understanding of their diagnosis an important determinant of outcome in occupational contact dermatitis? Contact Dermatitis 1991,25(5):296–301. 10.1111/j.1600-0536.1991.tb01877.xCrossRefPubMed
9.
Diepgen TL, Agner T, Aberer W, Berth-Jones J, Cambazard F, Elsner P, McFadden J, Coenraads PJ: Management of chronic hand eczema. Contact Dermatitis 2007, 57: 203–210. 10.1111/j.1600-0536.2007.01179.xCrossRefPubMed
10.
Agner T, Held E: Skin protection programmes. Contact Dermatitis 2002,47(5):253–256. 10.1034/j.1600-0536.2002.470501.xCrossRefPubMed
11.
Serup J, Lindblad AK, Maroti M, Kjellgren KI, Niklasson E, Ring L, Ahlner J, et al.: To follow or not to follow dermatological treatment–a review of the literature. Acta Derm Venereol 2006, 86: 193–197. 10.2340/00015555-0073CrossRefPubMed
12.
Storm A, Andersen SE, Benfeldt E, Serup J: One in 3 prescriptions are never redeemed: primary nonadherence in an outpatient clinic. J Am Acad Dermatol 2008,59(1):27–33. 10.1016/j.jaad.2008.03.045CrossRefPubMed
13.
Hodari KT, Nanton JR, Carroll CL, Feldman SR, Balkrishnan R: Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat 2006,17(3):136–142. 10.1080/09546630600688515CrossRefPubMed
14.
Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X: Interventions for enhancing medication adherence. Cochrane Database Syst Rev 2008, (Issue 2: Art. No):CD000011.
15.
16.
Bauer A, Schmitt J, Bennett C, Coenraads PJ, Elsner P, English J, Williams HC: Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev 2010, (Issue 6: Art. No.):CD004414.
17.
Winker R, Salameh B, Stolkovich S, Nikl M, Barth A, Ponocny E, Drexler H, Tappeiner G G: Effectiveness of skin protection creams in the prevention of occupational dermatitis: results of a randomized, controlled trial. Int Arch Occup Environ Health 2009, 82: 653–662. 10.1007/s00420-008-0377-2CrossRefPubMed
18.
Dulon M, Pohrt U, Skudlik C, Nienhaus A: Prevention of occupational skin disease: a workplace intervention study in geriatric nurses. Br J Dermatol 2009, 161: 337–344. 10.1111/j.1365-2133.2009.09226.xCrossRefPubMed
19.
Held E, Wolff C, Gyntelberg F, Agner T: Prevention of work-related skin problems in student auxiliary nurses: an intervention study. Contact Dermatitis 2001, 44: 297–303. 10.1034/j.1600-0536.2001.440509.xCrossRefPubMed
20.
Flyvholm MA, Mygind K, Sell L, Jensen A, Jepsen KF: A randomised controlled intervention study on prevention of work related skin problems among gut cleaners in swine slaughterhouses. Occup Environ Med 2005, 62: 642–649. 10.1136/oem.2004.016576CrossRefPubMedPubMedCentral
21.
Sell L, Flyvholm MA, Lindhard G, Mygind K: Implementation of an occupational skin disease prevention programme in Danish cheese dairies. Contact Dermatitis 2005, 53: 155–161. 10.1111/j.0105-1873.2005.00674.xCrossRefPubMed
22.
Matterne U, Diepgen TL, Weisshaar E: Effects of a health-educational and psychological intervention on socio-cognitive determinants of skin protection behaviour in individuals with occupational dermatoses. Int Arch Occup Environ Health 2010, 83: 183–189. 10.1007/s00420-009-0448-zCrossRefPubMed
23.
Relton C, Torgerson D, O'Cathain A, Nicholl J: Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ 2010, 340: c1066. 10.1136/bmj.c1066CrossRefPubMed
24.
Dean K: Self-care components of lifestyles: the importance of gender, attitudes and the social situation. Soc Sci Med 1989, 29: 137–152. 10.1016/0277-9536(89)90162-7CrossRefPubMed
25.
Nyberg F, Osika I, Evengard B: "The Laundry Bag Project"–unequal distribution of dermatological healthcare resources for male and female psoriatic patients in Sweden. Int J Dermatol 2008, 47: 144–149. 10.1111/j.1365-4632.2008.03485.xCrossRefPubMed
26.
27.
Lindberg M: Compliance - Om afvigelser mellem lægers ordinationer og patienternes faktiske medicinering [Compliance – on discrepancies between physicians’ prescriptions and patients’ actual medication]. Copenhagen: Institut for Rationel Farmakoterapi; 2006. Ref Type: Report. Available athttp://​www.​irf.​dk/​download/​pdf/​compliance.​pdf
28.
29.
30.
Perera R, Heneghan C, Yudkin P: Graphical method for depicting randomised trials of complex interventions. BMJ 2007, 334: 127–129. 10.1136/bmj.39045.396817.68CrossRefPubMedPubMedCentral
31.
Held E, Skoet R, Johansen JD, Agner T: The hand eczema severity index (HECSI): a scoring system for clinical assessment of hand eczema. A study of inter- and intraobserver reliability. Br J Dermatol 2005, 152: 302–307. 10.1111/j.1365-2133.2004.06305.xCrossRefPubMed
32.
Basra MK, Fenech R, Gatt RM, Salek MS, Finlay AY: The Dermatology Life Quality Index 1994–2007: a comprehensive review of validation data and clinical results. Br J Dermatol 2008, 159: 997–1035.PubMed
33.
Evers AW, Duller P, van de Kerkhof PCM, van der Valk PGM, de Jong EMGJ, Gerritsen MJP, Otero E, Verhoeven EWM, Verhaak CM, Kraaimaat FW: The Impact of Chronic Skin Disease on Daily Life (ISDL): a generic and dermatology-specific health instrument. Br J Dermatol 2008, 158: 101–108.PubMed
34.
35.
Miller MJ, Allison JJ, Schmitt MR, Ray MN, Funkhouser EM, Cobaugh DJ, et al.: Using single-item health literacy screening questions to identify patients who read written nonsteroidal anti-inflammatory medicine information provided at pharmacies. J Health Commun 2010, 15: 413–427. 10.1080/10810731003753091CrossRefPubMed
36.
Nutbeam D: Health Promotion Glossary - Moving towards a new public health. Geneva: World Health Organization; 1998. Ref Type: Report
37.
Powers BJ, Trinh JV, Bosworth HB: Can this patient read and understand written health information? JAMA 2010, 304: 76–84. 10.1001/jama.2010.896CrossRefPubMed
38.
Bandura A: Health promotion by social cognitive means. Health Educ Behav 2004, 31: 143–164. 10.1177/1090198104263660CrossRefPubMed
39.
Mikkelsen EG, Einarsen S: Relationships between exposure to bullying at work and psychological and psychosomatic health complaints: the role of state negative affectivity and generalized self-efficacy. Scand J Psychol 2002, 43: 397–405. 10.1111/1467-9450.00307CrossRefPubMed
40.
Jacobsen R, Moldrup C, Christrup L, Sjogren P, Hansen OB: The Danish version of the medication adherence report scale: preliminary validation in cancer pain patients. Pain Pract 2009, 9: 1–7.CrossRefPubMed
41.
Susitaival P, Flyvholm MA, Meding B, Kanerva L, Lindberg M, Svensson A, Olafsson JH: Nordic Occupational Skin Questionnaire (NOSQ-2002): a new tool for surveying occupational skin diseases and exposure. Contact Dermatitis 2003, 49: 70–76. 10.1111/j.0105-1873.2003.00159.xCrossRefPubMed
42.
Kristjansdottir J, Olsson GI, Sundelin C, Naessen T: Could SF-36 be used as a screening instrument for depression in a Swedish youth population? Scand J Caring Sci 2010, 25: 262–268.CrossRefPubMed
43.
Storm A, Benfeldt E, Andersen SE, Serup J: A prospective study of patient adherence to topical treatments: 95 % of patients underdose. J Am Acad Dermatol 2008, 59: 975–980. 10.1016/j.jaad.2008.07.039CrossRefPubMed
44.
Hald M, Agner T, Blands J, Veien NK, Laurberg G, Avnstorp C, Menné T, Kaaber K, Kristensen B, Kristensen O, Andersen KE, Paulsen E, Thormann J, Sommerlund M, Nielsen NH, Johansen JD: Clinical severity and prognosis of hand eczema. Br J Dermatol 2009, 160: 1229–1236. 10.1111/j.1365-2133.2009.09139.xCrossRefPubMed
45.
Holman R, Glas CA, de Haan RJ: Power analysis in randomized clinical trials based on item response theory. Control Clin Trials 2003, 24: 390–410. 10.1016/S0197-2456(03)00061-8CrossRefPubMed
46.
Francis JJ, Eccles MP, Johnston M, Walker A, Grimshaw J, Foy R, Kaner EFS, Smith L, Bonetti D: Constructing questionnaires based on the theory of planned behaviour. A manual for health services researchers 2004. 2010, 2–12. Ref Type: Report
47.
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P: Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008, 148: 295–309.CrossRefPubMed
48.
Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P: Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008, 148: W60-W66.PubMed
Metadata
Title
Chronic hand eczema - self-management and prognosis: a study protocol for a randomised clinical trial
Authors
Annette Mollerup
Niels Kren Veien
Jeanne Duus Johansen
Publication date
01-12-2012
Publisher
BioMed Central
Published in
BMC Dermatology / Issue 1/2012
Electronic ISSN: 1471-5945
DOI
https://doi.org/10.1186/1471-5945-12-6

Other articles of this Issue 1/2012

BMC Dermatology 1/2012 Go to the issue

Research article

Eczema in early childhood is strongly associated with the development of asthma and rhinitis in a prospective cohort

Research article

An urea, arginine and carnosine based cream (Ureadin Rx Db ISDIN) shows greater efficacy in the treatment of severe xerosis of the feet in Type 2 diabetic patients in comparison with glycerol-based emollient cream. A randomized, assessor-blinded, controlled trial

Research article

The spectrum of skin diseases in a rural setting in Cameroon (sub-Saharan Africa)

Research article

Morphometric characteristics of basal cell carcinoma peritumoral stroma varies among basal cell carcinoma subtypes

Research article

Skin flora: Differences between people affected by Albinism and those with normally pigmented skin in Northern Tanzania – cross sectional study

Study protocol

The hereditary angioedema burden of illness study in Europe (HAE-BOIS-Europe): background and methodology